In 7 trials, cortisol was lower with ashwagandha than a dummy pill; in 6, self-rated stress did not differ.
Review · 488 people · 2 weeks or longer · funding not stated
Albalawi, Nutrition and Health, 2025
Terms and sources
- ashwagandha
- extracts, 250 mg a day or more, for 2 weeks or longer; extract types not stated in the abstract
- cortisol
- cortisol, a stress hormone: 1.16 µg/dL lower; statistically significant
- self-rated stress
- Perceived Stress Scale; the difference was not statistically significant. 488 people in all.
- a dummy pill
- placebo
- funding not stated
- The abstract does not name who paid for the study or supplied the product. We could not open the full text.
Study · Abstract only · about 2 min to read
Our estimate at about 200 words a minute, from the PubMed abstract.
Study summary
A 2025 review combined randomized trials of ashwagandha extracts at 250 mg a day or more. The trials lasted at least 2 weeks. Seven trials measured cortisol, a stress hormone, and six measured self-rated stress; 488 people took part. Cortisol was 1.16 µg/dL lower than with a dummy pill. This difference was statistically significant. Self-rated stress did not differ from the dummy pill by a statistically significant amount. The abstract does not name the extracts or describe the people studied. Funding: not named in the abstract; we could not open the full text.
In 3 weight-training trials, strength rose more with ashwagandha than a dummy pill; a stricter test did not confirm it.
Review · 161 people · 8–12 weeks
Lee and Heo, Nutrients, 2026
Terms and sources
- weight-training trials
- Healthy adults on a weight-training program: 2 trials in men, 1 in men and women. KSM-66 or Sensoril, 500–600 mg a day.
- strength
- Heaviest single lift: bench press and leg exercises, effect sizes 0.60 and 0.52, statistically significant in the main analysis. Body fat did not differ.
- a dummy pill
- placebo
- a stricter test
- An adjustment for the small number of trials (Hartung–Knapp–Sidik–Jonkman). With it, neither strength result was statistically significant. The authors rated the certainty as low.
Study · Free full text · about 32 min to read
Our estimate at about 200 words a minute, from the PMC full text.
Study summary
A 2026 review combined randomized trials in which healthy adults took ashwagandha extract during weight training. Three trials with 161 people gave data that could be combined. They lasted 8 to 12 weeks and used KSM-66 or Sensoril. Gains in bench press and leg strength were larger than with a dummy pill. These differences were statistically significant in the main analysis. With an adjustment for the small number of trials, they were not. Body fat did not differ. Makers of the extracts funded or supplied all three trials. Funding: the review states no external funding.
Men in weight training took ashwagandha Sensoril; squat strength rose 19.1 kg, versus 10.0 kg with a dummy pill.
Trial · 38 analyzed · 12 weeks · maker-funded
Ziegenfuss et al., Nutrients, 2018
Also counted in Lee 2026
Terms and sources
- Men in weight training
- healthy, recreationally active men, average age 26.5
- Sensoril
- ashwagandha root-and-leaf water extract, 500 mg a day
- squat strength
- heaviest single squat, after 12 weeks. Bench press also rose more. One body-fat measure also differed; other body-composition measures and recovery did not.
- a dummy pill
- placebo
- maker-funded
- Natreon, maker of Sensoril, paid for the study and supplied the product.
Study · Free full text · about 22 min to read
Our estimate at about 200 words a minute, from the PMC full text.
Study summary
Researchers tested Sensoril, a water extract of ashwagandha root and leaf, in 40 healthy, recreationally active men; 38 were analyzed. One group took 500 mg a day and the other a dummy pill for 12 weeks. All followed the same weight-training program. Squat strength rose 19.1 kg with Sensoril and 10.0 kg with the dummy pill. Bench press rose 12.8 kg and 8.0 kg. Both differences were statistically significant. Most body-composition measures and recovery ratings did not differ between groups. Women were not studied. Funding: Natreon, maker of Sensoril, paid for the study and supplied the product.
Adults under stress took ashwagandha KSM-66 for 60 days; stress scores fell 44% versus 5.5% with a dummy pill.
Trial · 64 people · 60 days · maker-supplied
Chandrasekhar et al., Indian Journal of Psychological Medicine, 2012
Probably also counted in Albalawi 2025
Terms and sources
- Adults under stress
- aged 18–54, stress score 14 or higher; no illness or regular medicines
- KSM-66
- ashwagandha root extract, at least 5% withanolides, 300 mg twice a day
- stress scores
- Perceived Stress Scale, change from the start. Blood cortisol fell 27.9% versus 7.9%.
- a dummy pill
- placebo
- maker-supplied
- Ixoreal Biomed, maker of KSM-66, provided the extract. The article names no other funder.
Study · Free full text · about 17 min to read
Our estimate at about 200 words a minute, from the PMC full text.
Study summary
Researchers in India gave 64 adults under stress either KSM-66 ashwagandha root extract or a dummy pill. The extract dose was 300 mg twice a day for 60 days. People with illnesses or regular medicines were not included. Stress scores fell 44.0% with the extract and 5.5% with the dummy pill. Blood cortisol, a stress hormone, fell 27.9% and 7.9%. Both differences were statistically significant. Side effects were mild and similar in both groups. 61 people completed the study. Funding: the article names no funder; Ixoreal Biomed, maker of KSM-66, provided the extract.
Adults with unrefreshing sleep took ashwagandha Shoden for 6 weeks; sleep-quality scores rose 72%, versus 29% with a dummy pill.
Trial · 150 people · 6 weeks · funding not stated
Deshpande et al., Sleep Medicine, 2020
Terms and sources
- Adults with unrefreshing sleep
- healthy adults who scored high on a questionnaire about unrefreshing sleep; India
- Shoden
- ashwagandha extract, 120 mg once a day. Root and leaf, according to labels and a 2021 review. A 2019 trial funded by the maker calls it a root extract.
- sleep-quality scores
- Self-rated, on the Restorative Sleep Questionnaire. A wrist activity monitor also showed more total sleep and less time awake at night. These differences were statistically significant.
- a dummy pill
- placebo
- funding not stated
- The abstract does not name who paid for the study or supplied the product. We could not open the full text.
Study · Abstract only · about 2 min to read
Our estimate at about 200 words a minute, from the PubMed abstract.
Study summary
Researchers in India tested Shoden, an ashwagandha extract, in 150 healthy adults whose sleep felt unrefreshing. One group took 120 mg once a day and the other a dummy pill for 6 weeks. Self-rated sleep quality rose 72% with the extract and 29% with the dummy pill. A wrist activity monitor showed more total sleep and less time awake at night with the extract. These differences were statistically significant. 144 people completed the study, and no side effects linked to the extract were reported. Funding: not named in the abstract; we could not open the full text.
Healthy adults under stress took ashwagandha NooGandha for 30 days; stress scores did not differ from a dummy pill.
Trial · by group size; the paper also gives 60 · 30 days · maker-funded
Remenapp et al., Journal of Ayurveda and Integrative Medicine, 2022
Probably also counted in Albalawi 2025
Terms and sources
- Healthy adults under stress
- aged 18–54, stress score 14 or higher, no illness or regular medicines
- NooGandha
- ashwagandha root-and-leaf extract, 225 or 400 mg a day; 3 groups, 58 people
- 30 days
- Computer tests were also run. Reaction time slowed in all groups, least with 400 mg; the gap to the dummy pill was statistically significant. Visual memory scores fell in both ashwagandha groups.
- stress scores
- Perceived Stress Scale: scores fell over time in all groups, including the dummy pill.
- a dummy pill
- placebo
- maker-funded
- Specnova, maker of NooGandha, paid for the study.
Study · Free full text · about 9 min to read
Our estimate at about 200 words a minute, from the PMC full text.
Study summary
Researchers in the US tested NooGandha, an ashwagandha root-and-leaf extract, in 58 healthy adults under stress. They took 225 mg or 400 mg a day, or a dummy pill, for 30 days. Stress, mood and food-craving scores fell over time in all three groups. The difference between groups was not statistically significant. On computer tests, reaction time slowed in all groups, least with 400 mg. Its gap to the dummy pill was statistically significant. Saliva cortisol fell within the 225 mg group. Funding: Specnova, maker of NooGandha, paid for the study.
Stressed, tired adults aged 40–75 took ashwagandha Witholytin for 12 weeks; stress did not differ from a dummy pill.
Trial · 120 people · 12 weeks · maker-funded
Smith et al., Journal of Psychopharmacology, 2023
Probably also counted in Albalawi 2025
Terms and sources
- Stressed, tired adults aged 40–75
- healthy adults with self-rated stress and low energy; body mass index 25 to 35
- Witholytin
- ashwagandha root extract, 1.5% withanolides, 200 mg twice a day
- stress
- Perceived Stress Scale, the main measure; it fell in both groups. Tiredness, a second measure, fell more with ashwagandha.
- a dummy pill
- placebo
- maker-funded
- Verdure Sciences, maker of Witholytin, paid for the study and supplied the extract.
Study · Free full text · about 37 min to read
Our estimate at about 200 words a minute, from the PMC full text.
Study summary
Researchers in Australia tested Witholytin, an ashwagandha root extract, in 120 healthy adults aged 40 to 75. All reported stress and low energy and had a body mass index of 25 to 35. They took 200 mg twice a day or a dummy pill for 12 weeks. Stress scores fell in both groups; the difference was not statistically significant. Tiredness scores, a second measure, fell more with the extract. This difference was statistically significant. 111 people were analyzed. Funding: Verdure Sciences, maker of Witholytin, paid for the study and supplied the extract.
Healthy adults took ashwagandha extract for 8 weeks; blood, liver and thyroid tests did not differ from a dummy pill.
Trial · 80 people · 8 weeks · funding not stated
Verma et al., Complementary Therapies in Medicine, 2021
Terms and sources
- ashwagandha extract
- root extract, 300 mg twice a day; the brand is not named in the abstract
- blood, liver and thyroid tests
- Blood counts, blood chemistry, liver and thyroid tests, weight, pulse and other vital signs. No side effects were reported in either group. An 8-week trial of 80 people cannot show rare side effects.
- a dummy pill
- placebo
- funding not stated
- The abstract does not name who paid for the study or supplied the product. We could not open the full text.
Study · Abstract only · about 2 min to read
Our estimate at about 200 words a minute, from the PubMed abstract.
Study summary
Researchers in India tested ashwagandha root extract in 80 healthy adults, 40 men and 40 women. Half took 300 mg twice a day and half a dummy pill for 8 weeks. Blood counts, blood chemistry, liver tests and thyroid hormones were measured before and after. None changed by a statistically significant amount in either group. Weight, pulse and other vital signs did not change, and no side effects were reported. The abstract does not name the extract brand. Funding: not named in the abstract; we could not open the full text.